- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01617525
A Comparison of the Effects on Cardiovascular Risk Factors of Korean and American Dietary Profiles
May 10, 2016 updated by: USDA Beltsville Human Nutrition Research Center
The primary aim of this study is to compare, in a group of at-risk individuals, the role of three dietary patterns on indices of Cardiovascular Disease (CVD) risk: a) the recommended Korean pattern; b) the typical American diet, based on national dietary intake surveys; and c) the 2010 DGA diet pattern.
A secondary aim will be to assess the effects of each diet on intestinal microbiota and on inflammatory biomarkers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Beltsville, Maryland, United States, 20705
- USDA Beltsville Human Nutrition Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Non Asian-American men and women between the ages of 25-65 years
- Body Mass Index (BMI) ≥ 25 and ≤ 38 kg/m2
- Fasting LDL-cholesterol ≥ 130 mg/dL
- Willingness and ability to make scheduled appointments at clinical site as required by study protocol
Exclusion Criteria:
- Major aversions to Korean foods
- Known food allergies that would interfere with study protocol
- Use of cholesterol-lowering medication or dietary supplements
- Use of blood pressure medications
- Use of prebiotics or probiotics in the last 3 months
- Received medication for bacterial infection (antibiotic) in the last 3 months
- Regular use of fiber supplements or laxatives
- Conditions requiring ongoing medical care and/or medication, including kidney, liver, gastrointestinal or endocrine disorders.
- Regular tobacco use within 6 months prior to the start of the study
- History of eating disorders or other dietary patterns which are not consistent with the dietary intervention (e.g., vegetarians, very low fat diets, high protein diets)
- Voluntary or involuntary weight loss of 10% of body weight within the last 12 months
- Self-report of alcohol or substance abuse within the past 12 months
- Donated blood during the 8 week period prior to the study
- Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study anticipation or the ability to follow the intervention protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Korean Recommended Diet
A dietary pattern that follows the recommendations by the Korean Rural Development Administration.
|
All meals will be provided during each 4-week intervention period.
Participants must consume all foods provided and must not consume any outside foods during each intervention period.
|
|
Active Comparator: US Recommended Diet
Diet based on recipes and menus developed by the USDA Dietary Guidelines for Americans intramural team.
|
All meals will be provided during each 4-week intervention period.
Participants must consume all foods provided and must not consume any outside foods during each intervention period.
|
|
Active Comparator: Typical American Diet
Diet based on data from the NHANES surveys, as summarized in the USDA report What We Eat in America.
|
All meals will be provided during each 4-week intervention period.
Participants must consume all foods provided and must not consume any outside foods during each intervention period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiovascular Disease Biomarkers
Time Frame: End of each 4-week diet period
|
Plasma total cholesterol, HDL and LDL cholesterol, insulin, glucose, and serum triglycerides will be measured.
|
End of each 4-week diet period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inflammatory Markers
Time Frame: End of each 4-week diet
|
Cytokine production will be analyzed by selecting representative pro-inflammatory cytokine genes (i.e.
TNF-a, IL-12, IL-6, IFNg), anti-inflammatory genes (IL-10), and different signaling pathways (i.e.
Mitogen activated protein kinase (MAPK) p38, phosphatidylinositol 3 (PI3) kinase, and nuclear factor Kappa B (NF-KB).
|
End of each 4-week diet
|
|
Markers of appetite and food intake regulation
Time Frame: End of each 4-week diet
|
Plasma adiponectin, ghrelin, PYY and leptin will be measured.
|
End of each 4-week diet
|
|
Blood pressure
Time Frame: End of each 4-week diet
|
End of each 4-week diet
|
|
|
Urinary sodium excretion, potassium, urea nitrogen, phosphorus, and creatinine
Time Frame: End of each 4-week diet
|
End of each 4-week diet
|
|
|
Change in fecal microbiota
Time Frame: At baseline and after 4-weeks of each diet
|
Fecal samples will be collected to study changes in bacterial abundance of commensal microorganisms such as Bifidobacterium spp., Lactobacillus spp., E.coli spp.
and Bacteroides fragilis spp.
|
At baseline and after 4-weeks of each diet
|
|
Dietary Questionnaires
Time Frame: At end of each 4-week diet
|
Participants will be asked to complete questionnaires regarding acceptability, satiety, and gastrointestinal symptoms.
|
At end of each 4-week diet
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
March 31, 2012
First Submitted That Met QC Criteria
June 11, 2012
First Posted (Estimate)
June 12, 2012
Study Record Updates
Last Update Posted (Estimate)
May 11, 2016
Last Update Submitted That Met QC Criteria
May 10, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Korean Diet Study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypercholesterolemia
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryActive, not recruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
-
Institut Investigacio Sanitaria Pere VirgiliRecruitingFamilial Hypercholesterolemia | Familial Hypercholesterolemia - Homozygous | Familial Hypercholesterolemia - HeterozygousSpain
-
Direct PlantesUnknownHYPERCHOLESTEROLEMIAFrance
-
Novartis PharmaceuticalsNot yet recruitingDyslipidemia, Hypercholesterolemia
-
Shanghai General Hospital, Shanghai Jiao Tong University...Accuredit Therapeutics US LimitedNot yet recruitingHeterozygous Familial HypercholesterolemiaChina
-
Hangzhou Dinovate Biotech Co., LtdNot yet recruitingPrimary Hypercholesterolemia
-
Addpharma Inc.Not yet recruitingPrimary Hypercholesterolemia
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Salubris (Chengdu) Biotechnology Co., Ltd.CompletedHypercholesterolemia and Mixed DyslipidemiaChina
-
Provident Clinical ResearchGlaxoSmithKlineCompletedPrimary HypercholesterolemiaUnited States
Clinical Trials on Controlled Feeding Dietary Intervention
-
National Institute of Diabetes and Digestive and...Completed
-
Fred Hutchinson Cancer CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedControlled Feeding Trial | Healthy Eating Index | Red Meat | MeatUnited States
-
St. Vincent's Medical CenterInflammation Research Foundation, Marblehead, MA.; NeuroScience, Inc., Osceola...CompletedSleep DeprivationUnited States
-
Penn State UniversityMcCormick Science InstituteCompletedInflammation | Cardiovascular DiseaseUnited States
-
Indiana UniversityNational Center for Advancing Translational Sciences (NCATS)RecruitingChronic Kidney Disease Stage 3United States
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Purdue... and other collaboratorsActive, not recruiting
-
Marian NeuhouserDuke University; University of Washington; University of Nebraska; United States...Completed
-
Harvard School of Public Health (HSPH)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiet, Healthy | Biological Markers | Nutrition, Healthy | MetabolomicsUnited States
-
Ohio State UniversityMalaysia Palm Oil BoardCompletedCardiovascular Diseases | InflammationUnited States
-
Hacettepe UniversityNot yet recruitingPolycystic Ovarian Syndrome (PCOS)